231 related articles for article (PubMed ID: 38463108)
1. Cardiovascular risk assessment in inflammatory bowel disease with coronary calcium score.
Chaudhry WAR; Ashfaq M; Kaur P; Kumar M; Faraz M; Malik J; Mehmoodi A
Ann Med Surg (Lond); 2024 Mar; 86(3):1496-1505. PubMed ID: 38463108
[TBL] [Abstract][Full Text] [Related]
2. Navigating the Gut-Cardiac Axis: Understanding Cardiovascular Complications in Inflammatory Bowel Disease.
Sinha T; Zain Z; Bokhari SFH; Waheed S; Reza T; Eze-Odurukwe A; Patel M; Almadhoun MKIK; Hussain A; Reyaz I
Cureus; 2024 Feb; 16(2):e55268. PubMed ID: 38558708
[TBL] [Abstract][Full Text] [Related]
3. Coronary artery calcium scoring for cardiovascular risk assessment in patients with inflammatory bowel disease.
Naami R; Tashtish N; Neeland IJ; Katz J; Sinh P; Nasir K; Chittajallu V; Mansoor E; Rajagopalan S; Al-Kindi S
Am Heart J; 2023 Dec; 266():120-127. PubMed ID: 37634654
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory Bowel Disease and Atherosclerotic Cardiovascular Disease: JACC Review Topic of the Week.
Cainzos-Achirica M; Glassner K; Zawahir HS; Dey AK; Agrawal T; Quigley EMM; Abraham BP; Acquah I; Yahya T; Mehta NN; Nasir K
J Am Coll Cardiol; 2020 Dec; 76(24):2895-2905. PubMed ID: 33303079
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory bowel disease and the risk for cardiovascular disease: Does all inflammation lead to heart disease?
Bigeh A; Sanchez A; Maestas C; Gulati M
Trends Cardiovasc Med; 2020 Nov; 30(8):463-469. PubMed ID: 31653485
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular implications of inflammatory bowel disease: An updated review.
Bhardwaj A; Singh A; Midha V; Sood A; Wander GS; Mohan B; Batta A
World J Cardiol; 2023 Nov; 15(11):553-570. PubMed ID: 38058397
[TBL] [Abstract][Full Text] [Related]
7. Association of Cardiovascular Disease Risk Factor Burden With Progression of Coronary Atherosclerosis Assessed by Serial Coronary Computed Tomographic Angiography.
Han D; Berman DS; Miller RJH; Andreini D; Budoff MJ; Cademartiri F; Chinnaiyan K; Choi JH; Conte E; Marques H; de Araújo Gonçalves P; Gottlieb I; Hadamitzky M; Leipsic J; Maffei E; Pontone G; Shin S; Kim YJ; Lee BK; Chun EJ; Sung JM; Lee SE; Virmani R; Samady H; Stone P; Narula J; Bax JJ; Shaw LJ; Lin FY; Min JK; Chang HJ
JAMA Netw Open; 2020 Jul; 3(7):e2011444. PubMed ID: 32706382
[TBL] [Abstract][Full Text] [Related]
8. Impact of lipid-lowering therapies on cardiovascular outcomes according to coronary artery calcium score. A systematic review and meta-analysis.
Gallone G; Elia E; Bruno F; Angelini F; Franchin L; Bocchino PP; Piroli F; Annone U; Montabone A; Marengo G; Bertaina M; De Filippo O; Baldetti L; Palmisano A; Serafini A; Esposito A; Depaoli A; D'ascenzo F; Fonio P; De Ferrari GM
Rev Esp Cardiol (Engl Ed); 2022 Jun; 75(6):506-514. PubMed ID: 34483065
[TBL] [Abstract][Full Text] [Related]
9. Effects of intensive lipid lowering compared with moderate-intensity lipid lowering on coronary atherosclerotic plaque phenotype and major adverse cardiovascular events in adults with low to intermediate 10-year ASCVD risk (ILLUMINATION study): protocol for a multicentre, open-label, blinded-endpoint, randomised controlled trial.
Zheng J; Hou Z; Yuan J; Zhao X; Wang Y; Li J; Zhang W; Dou K; Lu B
BMJ Open; 2023 Jun; 13(6):e070832. PubMed ID: 37277217
[TBL] [Abstract][Full Text] [Related]
10. Accuracy of Pooled-Cohort Equation and SCORE cardiovascular risk calculators to identify individuals with high coronary atherosclerotic burden - implications for statin treatment.
Tralhão A; Ferreira AM; Gonçalves Pde A; Rodrigues R; Costa C; Guerreiro S; Cardim N; Marques H
Coron Artery Dis; 2016 Nov; 27(7):573-9. PubMed ID: 27285280
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory bowel disease and atherosclerotic cardiovascular disease in U.S. adults-A population-level analysis in the national health interview survey.
Nasir K; Acquah I; Dey AK; Agrawal T; Hassan SZ; Glassner K; Abraham B; Quigley EMM; Blankstein R; Virani SS; Blaha MJ; Valero-Elizondo J; Cainzos-Achirica M; Mehta NN
Am J Prev Cardiol; 2022 Mar; 9():100316. PubMed ID: 35112094
[TBL] [Abstract][Full Text] [Related]
12. Atherosclerotic cardiovascular disease risk assessment: An American Society for Preventive Cardiology clinical practice statement.
Wong ND; Budoff MJ; Ferdinand K; Graham IM; Michos ED; Reddy T; Shapiro MD; Toth PP
Am J Prev Cardiol; 2022 Jun; 10():100335. PubMed ID: 35342890
[TBL] [Abstract][Full Text] [Related]
13. Atherosclerotic cardiovascular disease in inflammatory bowel disease: The role of chronic inflammation.
Weissman S; Sinh P; Mehta TI; Thaker RK; Derman A; Heiberger C; Qureshi N; Amrutiya V; Atoot A; Dave M; Tabibian JH
World J Gastrointest Pathophysiol; 2020 Aug; 11(5):104-113. PubMed ID: 32832194
[TBL] [Abstract][Full Text] [Related]
14. Subclinical Hypertension-Mediated Organ Damage (HMOD) in Hypertension: Atherosclerotic Cardiovascular Disease (ASCVD) and Calcium Score.
Rizzoni D; Agabiti-Rosei C; De Ciuceis C; Boari GEM
High Blood Press Cardiovasc Prev; 2023 Jan; 30(1):17-27. PubMed ID: 36376777
[TBL] [Abstract][Full Text] [Related]
15. Coronary Artery Calcium in Assessment of Atherosclerotic Cardiovascular Disease Risk and its Role in Primary Prevention.
Hisamatsu T; Kinuta M
J Atheroscler Thromb; 2023 Oct; 30(10):1289-1302. PubMed ID: 37394660
[TBL] [Abstract][Full Text] [Related]
16. Thromboembolic and atherosclerotic cardiovascular events in inflammatory bowel disease: epidemiology, pathogenesis and clinical management.
Sleutjes JAM; van Lennep JER; van der Woude CJ; de Vries AC
Therap Adv Gastroenterol; 2021; 14():17562848211032126. PubMed ID: 34377149
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of cardiovascular risk factors in a nationally representative adult population with inflammatory bowel disease without atherosclerotic cardiovascular disease.
Agrawal T; Acquah I; Dey AK; Glassner K; Abraham B; Blankstein R; Virani SS; Blaha MJ; Valero-Elizondo J; Mehta N; Quigley EM; Cainzos-Achirica M; Nasir K
Am J Prev Cardiol; 2021 Jun; 6():100171. PubMed ID: 34327497
[TBL] [Abstract][Full Text] [Related]
18. Contemporary use of coronary artery calcium for the allocation of aspirin in light of the 2022 USPSTF guideline recommendations.
Verghese D; Manubolu S; Budoff MJ
Am J Prev Cardiol; 2022 Dec; 12():100427. PubMed ID: 36407963
[TBL] [Abstract][Full Text] [Related]
19. Elevated lipoprotein(a) levels are associated with coronary artery calcium scores in asymptomatic individuals with a family history of premature atherosclerotic cardiovascular disease.
Verweij SL; de Ronde MWJ; Verbeek R; Boekholdt SM; Planken RN; Stroes ESG; Pinto-Sietsma SJ
J Clin Lipidol; 2018; 12(3):597-603.e1. PubMed ID: 29550494
[TBL] [Abstract][Full Text] [Related]
20. The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBD.
Carroll MW; Kuenzig ME; Mack DR; Otley AR; Griffiths AM; Kaplan GG; Bernstein CN; Bitton A; Murthy SK; Nguyen GC; Lee K; Cooke-Lauder J; Benchimol EI
J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S49-S67. PubMed ID: 31294385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
